Kathleen E. Walsh - Jun 10, 2021 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Director
Signature
Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Jun 10, 2021
Transactions value $
$0
Form type
4
Date filed
6/14/2021, 07:53 AM
Next filing
Sep 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Award $0 +3.13K $0.00 3.13K Jun 10, 2021 Common Stock 3.13K $87.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date.